Eye Health

GLP-1 NAION claims are gaining attention as patients report sudden vision loss after using certain medications for diabetes or weight management. The legal cases are still developing, and no standard settlement amounts have been established. For patients, the key issues are diagnosis, drug history, timing, risk factors, and whether medical records support a possible claim. […]

GLP-1 NAION attorneys are reviewing a growing category of vision-loss claims involving drugs used for diabetes and weight management. The cases are still developing, and no public settlement program has established standard payout amounts. For patients, early legal reviews often focus on diagnosis, drug timing, medical risk factors, warning evidence, and whether the claim fits […]

GLP-1 drugs such as Ozempic, Wegovy, and similar medications are widely used for type 2 diabetes and weight management. However, reports and research have raised questions about a possible link between GLP-1 drugs and NAION, a rare form of optic nerve damage. For patients who develop sudden vision loss, it’s important to understand which steps […]

GLP-1 NAION claims are drawing attention as patients and lawyers examine alleged links between certain diabetes and weight-loss drugs and sudden vision loss. But lawsuits do not automatically mean a recall is coming. For patients, it’s important to understand that legal claims, safety-label reviews, and recalls are separate processes with different standards and possible outcomes. […]